Farther Finance Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331K | Buy |
631
+3
| +0.5% | +$1.57K | 0.01% | 1121 |
|
|
2025
Q1 | $387K | Buy |
628
+55
| +10% | +$33.9K | 0.01% | 911 |
|
|
2024
Q4 | $409K | Sell |
573
-151
| -21% | -$108K | 0.01% | 670 |
|
|
2024
Q3 | $761K | Buy |
724
+53
| +8% | +$55.7K | 0.03% | 439 |
|
|
2024
Q2 | $710K | Buy |
671
+31
| +5% | +$32.8K | 0.03% | 375 |
|
|
2024
Q1 | $621K | Buy |
640
+4
| +0.6% | +$3.88K | 0.04% | 345 |
|
|
2023
Q4 | $558K | Buy |
636
+149
| +31% | +$131K | 0.04% | 327 |
|
|
2023
Q3 | $401K | Buy |
487
+190
| +64% | +$156K | 0.06% | 237 |
|
|
2023
Q2 | $213K | Buy |
297
+189
| +175% | +$136K | 0.05% | 302 |
|
|
2023
Q1 | $88.7K | Buy |
108
+2
| +2% | +$1.64K | 0.03% | 433 |
|
|
2022
Q4 | $76.5K | Buy |
+106
| New | +$76.5K | 0.03% | 387 |
|